|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias und Lenz, Georg
(2022):
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
In: British Journal of Haematology, Bd. 198, Nr. 3: S. 482-491
Keppler-Hafkemeyer, Andrea; Greil, Christine; Wratil, Paul R.; Shoumariyeh, Khalid; Stern, Marcel; Hafkemeyer, Annika; Ashok, Driti; Hollaus, Alexandra; Lupoli, Gaia; Priller, Alina; Bischof, Marie L.; Ihorst, Gabriele; Engelhardt, Monika; Marks, Reinhard; Finke, Juergen; Bertrand, Hannah; Daechert, Christopher; Muenchhoff, Maximilian; Badell, Irina; Emmerich, Florian; Halder, Hridi; Spaeth, Patricia M.; Knolle, Percy A.; Protzer, Ulrike; Bergwelt-Baildon, Michael von; Duyster, Justus; Hartmann, Tanja N.; Moosmann, Andreas und Keppler, Oliver T.
(2022):
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma.
In: Nature Cancer, Bd. 4, Nr. 1: S. 81-95
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636